The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Partridge Andrew John since 2021.
This trader's CIK number is 1758838.
At the time of last reporting, Partridge Andrew John was the EVP & Chief Commercial Officer of Turning Point Therapeutics, Inc.. (stock ticker symbol TPTX).
Also see all insider trading activities at Turning Point Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2022 | TPTX | 0 | $0 | 221 | $8,022 | 0 | $0 |
| 2021 | TPTX | 0 | $0 | 1,869 | $139,988 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2022-02-09 | TPTX | Sale | 221 | 36.30 | 8,022 |
| 2021-07-14 | TPTX | Sale | 1,869 | 74.90 | 139,988 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Partridge Andrew John (EVP & Chief Commercial Officer of Turning Point Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.